Fraud and Safety Concerns Surround Antibiotic Ketek
The Wall Street Journal recently reported that Senator Grassley of the Senate Finance Committee demanded a probe into the FDA's handling of safety concerns with the popular antibiotic Ketek. Produced by Sanofi-Aventis, the drug is being linked to liver failure and deaths.
Most disturbing is the fact that a researcher who worked on a major study of Ketek pleaded guilty to charges that she fraudulently reported false and inaccurate data to the study. The FDA required Sanofi-Aventis to perform the study after earlier studies raised concerns about the liver toxicity of the drug. The full extent of the problems relating to the study in question have not been fully revealed to the public.
Read more in the Wall Street Journal online here.
Post A Comment / Question